A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder
Status:
Completed
Trial end date:
2019-01-02
Target enrollment:
Participant gender:
Summary
To demonstrate the efficacy of brexpiprazole for the acute treatment of manic episodes, with
or without mixed features, in participants with a diagnosis of bipolar I disorder.
Phase:
Phase 3
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.